维普期刊资源整合服务平台（V6.5）

497篇 您的检索式：作者名="THONGPRASERT S"

选中清除导出查看参考文献查看引证文献引用追踪共25页首页上一页第1页下一页末页 /25 跳转

	题名	作者	年代	出处	被引量
1	Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma显示文摘	MOK T S WU Y L THONGPRASERT S	2009	N Engl J Med2009，361，10：	1
2	Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma显示文摘	Mok TS Wu YL Thongprasert S	2009	N Engl J Med2009，361，10：	1
3	Gefitinib or carboplat- in-paclitaxel in pulmonary adenocarcinoma显示文摘	Mok TS Wu YL Thongprasert S	2009	N EnglJ Med2009，361，10：	1
4	Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma显示文摘	Mok T S Wu Y L Thongprasert S	2009	N Engl J Med2009，361，10：	1
5	Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma显示文摘	Mok TS Wu YL Thongprasert S	2009	N Engl J Med2009，361，10：	1
6	Biomarker analyses and final overall survival results from a phase Ⅲ,randomized, open-label,first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients'with advanced non-small- cell lung cancer in Asia (IPASS) 显示文摘	Fukuoka M Wu YL Thongprasert S	2011	J Clin Oncol2011，29，21：	1
7	Gefitinib or Carboplatin - Paclitaxel in pulmonary adenocarcinoma 显示文摘	Mok TS Wu YL Thongprasert S	2009	N Engl J Med2009，361，10：	1
8	Gefitinib or carboplatin- paelitaxel in pulmonaoT adenoearcinoma显示文摘	Mok TS Wu YL Thongprasert S	2009	N Engl J Med2009，361，10：	1
9	Gefitinib or carbo- platin-paelitaxel in pulmonary adenocarcinoma显示文摘	Mok TS Wu YL Thongprasert S	2009	N Engl J Med2009，361，1：	1
10	PhaseⅢtrial of vandetanib compared with erlotinib in patients with previously treated advanced non-small-cell lung cancer显示文摘	Natale RB Thongprasert S Greco FA	2011	J Clin Oncol2011，29，8：	1
11	Phase m trial of vandetanib compared with erlotinib in patients with previously treated advanced non-small-cell lung cancer 显示文摘	Natale RB Thongprasert S Greco FA	2011	J Clin Oncol2011，29，8：	1
12	Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma显示文摘	MOK TS WU YL THONGPRASERT S	2009	N EnglJ Med2009，361，10：	1
13	Gefitinib or carboplatin --paclitaxel in pulmonary adenocarcinoma显示文摘	Mok T S Wu Y L Thongprasert S	2009	N Engl J Med2009，361，10：	1
14	Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma显示文摘	MokTS Wu YL Thongprasert S	2009	N Engl J Med2009，361，10：	1
15	Biomarker analyses from a phase llI, randomized, open-label, first-line study of gefitinib (G) versus carboplatin/paclitaxel (C/P) in clinically selected patients (pts) with advanced non-small cell lung cancer (NSCLC) in Asia (IPASS) 显示文摘	Fukuoka M Wu YP Thongprasert S	2009	J Clin Oncol2009，27，15：	1
16	Phase Ⅲ trial of vandetanib compared with erlotinib in patients with previously treated advanced non-small-cell lung cancer 显示文摘	Natale RB Thongprasert S Greco FA	2011	J Clin Oncol2011，29，8：	1
17	Gefitinib or Carboplatin - Paclitaxel in Pulmonary Adenocarcinoma 显示文摘	MOK T WU YL THONGPRASERT S	2009	The New England Journal of Medicine2009，361，10：	1
18	Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma显示文摘	Mok TS Wu YL Thongprasert S	2009	N Engl J Med2009，361，10：	1
19	Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma显示文摘	Mok TS Wu YL Thongprasert S		0，，10：	1
20	Gefitinib or car- boplatin paelitaxel in pulmonary, adenocarcinoma 显示文摘	Mok TS Wu YL Thongprasert S	2009	N Engl J Med2009，361，10：	1

返回顶部每页显示：

共25页首页上一页第1页下一页末页 /25 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示